Angiogenex Inc AGGX:OTC Pink - No Information (Common Stock)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
0.135 0.00   0.00% 2,500750
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 10/8/2014

Latest News Headlines for Angiogenex Inc

No News for Angiogenex Inc

Company Background

AngioGenex, Inc. (AngioGenex) is a development-stage company. The Company is a biopharmaceutical company focused on the manufacturing of products for the treatment, diagnosis and prognosis of cancer. The Company focuses to develop orally active anti-cancer drugs that act by modulating the action of the inhibitor of differentiation (Id) proteins, measurement of Id proteins in tumors and blood to create products for the diagnosis and prognosis of cancer and generating proof-of-concept data in relevant preclinical models to establish that modulation of Id genes and proteins is useful to treat non-oncologic diseases in which a surplus or deficit in the growth of blood vessels is an important part of the underlying pathology.

http://www.angiogenex.com

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open0.135
Previous Close0.135
Day High--
Day Low--
52 Week High7/14/2014 | 0.40
52 Week Low10/25/2013 | 0.0015
% Off 52 Week High(66.25)%
% Off 52 Week Low8,900.00%
Beta (5 Yr)--
Volatility Avg10/8/2014 | --
10-Day Avg. Volume750
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)9/30/2009 | (0.02)
P/E Ratio9/30/2009 | --
Market CapMicro Cap | 3M
Shares Outstanding21.30M
Float16.5M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield--
Ex-Date--
Dividend Announcement--
Date of Record--
Payable-- - --
Payable Date--

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short--
Short Ratio--
Short % of Float--
As of --

Peers Information HelpAGGX Angiogenex Inc vs. Peers

Peers 
AGGX
Angiogenex Inc
237.50%
Pfizer Inc.
-4.08%
Merck & Co., Inc.
20.24%
Bristol Myers Squibb Co.
-5.53%
Eli Lilly & Co.
27.92%
AGGX
Angiogenex Inc
0.00%
Pfizer Inc.
3.54%
Merck & Co., Inc.
2.92%
Bristol Myers Squibb Co.
2.87%
Eli Lilly & Co.
3.00%
AGGX
Angiogenex Inc
0.00%
Pfizer Inc.
2.05%
Merck & Co., Inc.
2.94%
Bristol Myers Squibb Co.
0.88%
Eli Lilly & Co.
1.59%
Compare these stocks